Pharma Manufacturing

16/12/2024

Novo Nordisk has announced it is investing $1.2 billion to build a new rare disease drug production facility in Odense, Denmark, which will include a warehouse. Slated to be completed in 2027, the plant will produce drugs for rare diseases including the inherited blood disorder hemophilia.

Novo Nordisk

https://www.pharmamanufacturing.com/industry-news/news/55249790/novo-nordisk-to-invest-12b-in-new-rare-disease-drug-plant-in-denmark

13/12/2024

See what you may have missed this week in the Pharma Industry with this Editors' (re)View, where our Editor in Chief, Greg Slabodkin, discusses the future of the BIOSECURE Act.

The proposed legislation, which seeks to prevent federally funded U.S. pharma companies from working with certain Chinese services firms, was excluded from a key defense bill last weekend with passage before the end of the congressional session now in question.

The proposed legislation, which prevents U.S. federal funds from supporting certain Chinese contract manufacturers, was omitted from a defense bill leaving its fate in limbo.

13/12/2024

Industry trade groups, including the Alliance for Regenerative Medicine (ARM), Biotechnology Industry Organization (BIO), and Pharmaceutical Research and Manufacturers of America (PhRMA), have provided comments and suggestions for the FDA’s draft strategy on the use of innovative manufacturing technologies.



https://www.pharmamanufacturing.com/industry-news/news/55249613/biopharma-groups-seek-changes-to-fdas-innovative-manufacturing-strategy

12/12/2024

Targeting customers from small biotechs to Big Pharma, Swiss-based contract development and manufacturing organization Lonza announced it is restructuring the company with an increased focus on its core CDMO business.

Lonza Group

https://www.pharmamanufacturing.com/industry-news/news/55249214/lonza-to-exit-capsules-and-health-ingredients-business-focus-on-cdmo-services

12/12/2024

Saudi Arabia’s Ministry of Industry and Mineral Resources, in collaboration with the Ministries of Investment and Health, signed a memorandum of understanding (MoU) with Vertex Pharmaceuticals to localize gene therapy manufacturing in the Kingdom.

Vertex

https://www.pharmamanufacturing.com/industry-news/news/55249198/vertex-saudi-arabia-to-collaborate-on-gene-therapy-manufacturing

11/12/2024

Cellipont Bioservices, a cell therapy contract development and manufacturing organization, has partnered with Xiogenix, a biopharma technology company, to integrate advanced filling systems into its manufacturing processes.

The teaming provides Cellipont with access to Xiogenix’s Ares X20 fill-and-finish system.

The teaming provides Cellipont with access to Xiogenix’s Ares X20 fill-and-finish system.

11/12/2024

NewBiologix, a Swiss technology company specializing in viral vector production for cell and gene therapies, has announced the opening of its new U.S. subsidiary.

The Swiss biotech, focused on cell and gene therapy (CGT) production, has launched a new U.S. subsidiary.

10/12/2024

Ori Biotech and Fresenius Kabi have announced a collaboration to integrate Ori’s IRO platform with Fresenius’ Cue and Lovo cell processing systems.

OriBiotech Fresenius Kabi

The collaboration is intended to create a connected workflow for cell and gene therapy (CGT) manufacturing.

10/12/2024

BioMarin Pharmaceutical has announced a $63 million (€60 million) investment to expand its manufacturing site in Shanbally, Cork, Ireland.

The Shanbally location is BioMarin’s only manufacturing site outside the U.S., which includes an aseptic production facility opened last year.

09/12/2024

Give this episode of Off Script: A Pharma Manufacturing Podcast a listen! Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly.

In this episode:
The good — FDA approves Imkeldi oral solution
The bad — Alector axes workforce
The ugly — Novartis announces layoffs

Listen now with the link below or find us on your favorite podcast streaming service.



https://pharmamanu.podbean.com/e/fda-approves-imkeldi-oral-solution-alector-axes-workforce-novartis-announcnes-layoffs-the-good-the-bad-the-ugly/

09/12/2024

Five Chinese biotechnology companies have avoided being barred from U.S.-funded research and contracts after congressional negotiators on a key defense bill excluded the proposed legislation on Saturday from the military spending package.



https://www.pharmamanufacturing.com/industry-news/news/55248249/biosecure-act-left-out-of-us-defense-budget-bill-provides-reprieve-to-chinese-biotechs

06/12/2024

See what you may have missed this week in Pharma with our Editors' (re)View, where our editors comment on the notable happenings in the industry.

This week, drug manufacturers—including Amgen, Eli Lilly, Novo Nordisk and Sanofi— announced plans to expand their production footprints in the U.S., Europe and Asia.

Read the full article with the link below!

This week, drug manufacturers —including Amgen, Eli Lilly, Novo Nordisk and Sanofi — announced plans to expand their production footprints in the U.S., Europe and Asia.